Page 2 - Positive Phase News Today

– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...

/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology·        Positive Phase 1 clinical results published in 'The Journal of Immunology’ (online)· &...

Positive Phase 1 clinical results published in 'The Journal of Immunology' (online) Two ongoing Phase 2 clinical trials in Ulcerative Colitis and primary Sjögren's Syndrome Positive

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland – October 25, 2022Idorsia Ltd (SIX: IDIA) today announced its financial results for the...

11.08.2022 - -Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022- -The UK’s Medicines and Healthcare Products Regulatory Agency Informed the Company that its Sabizabulin Marketing Authorization Application Will ...

Investegate announcements from BioNTech SE, Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO

(2022-05-09 | NDAQ:VBIV) VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytrens Disease Study Results in The Lancet Rheumatology · ... | May 2, 2022